These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 34203060)

  • 1. SARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia.
    Vilibic-Cavlek T; Stevanovic V; Ilic M; Barbic L; Capak K; Tabain I; Krleza JL; Ferenc T; Hruskar Z; Topic RZ; Kaliterna V; Antolovic-Pozgain A; Kucinar J; Koscak I; Mayer D; Sviben M; Antolasic L; Milasincic L; Bucic L; Ferencak I; Kaic B
    Pathogens; 2021 Jun; 10(6):. PubMed ID: 34203060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of SARS-CoV-2 in Croatian solid-organ transplant recipients.
    Mrzljak A; Jureković Ž; Pavičić-Šarić J; Stevanović V; Tabain I; Hruškar Ž; Mikulić D; Barbić L; Vilibić-Čavlek T
    Biochem Med (Zagreb); 2021 Oct; 31(3):030901. PubMed ID: 34658649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of SARS-CoV-2 IgG Antibodies in Corsica (France), April and June 2020.
    Capai L; Ayhan N; Masse S; Canarelli J; Priet S; Simeoni MH; Charrel R; Lamballerie X; Falchi A
    J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33167563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of SARS-CoV-2 Antibodies: Comparison of Enzyme Immunoassay, Surrogate Neutralization and Virus Neutralization Test.
    Vilibic-Cavlek T; Bogdanic M; Borko E; Hruskar Z; Zilic D; Ferenc T; Tabain I; Barbic L; Vujica Ferenc M; Ferencak I; Stevanovic V
    Antibodies (Basel); 2023 May; 12(2):. PubMed ID: 37218901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of High-Throughput SARS-CoV-2 Serological Assays in a Longitudinal Cohort of Patients with Mild COVID-19: Clinical Sensitivity, Specificity, and Association with Virus Neutralization Test.
    Bal A; Pozzetto B; Trabaud MA; Escuret V; Rabilloud M; Langlois-Jacques C; Paul A; Guibert N; D'Aubarède-Frieh C; Massardier-Pilonchery A; Fabien N; Goncalves D; Boibieux A; Morfin-Sherpa F; Pitiot V; Gueyffier F; Lina B; Fassier JB; Trouillet-Assant S;
    Clin Chem; 2021 Apr; 67(5):742-752. PubMed ID: 33399823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Anti-SARS-CoV-2 Antibodies in Poznań, Poland, after the First Wave of the COVID-19 Pandemic.
    Lorent D; Nowak R; Roxo C; Lenartowicz E; Makarewicz A; Zaremba B; Nowak S; Kuszel L; Stefaniak J; Kierzek R; Zmora P
    Vaccines (Basel); 2021 May; 9(6):. PubMed ID: 34064028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging Trends in the Epidemiology of COVID-19: The Croatian 'One Health' Perspective.
    Vilibic-Cavlek T; Stevanovic V; Brlek-Gorski D; Ferencak I; Ferenc T; Ujevic-Bosnjak M; Tabain I; Janev-Holcer N; Perkovic I; Anticevic M; Bekavac B; Kaic B; Mrzljak A; Ganjto M; Zmak L; Mauric Maljkovic M; Jelicic P; Bucic L; Barbic L
    Viruses; 2021 Nov; 13(12):. PubMed ID: 34960623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [SARS-CoV-2 Seroprevalence Among Healthcare Workers: Retrospective Analysis of the Data From A University Hospital in Turkey].
    Özdemir A; Demir Çuha M; Telli Dizman G; Alp A; Metan G; Şener B
    Mikrobiyol Bul; 2021 Apr; 55(2):223-232. PubMed ID: 33882653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of neutralizing antibody responses against SARS-CoV-2 in COVID-19 patients.
    Teresa Valenzuela M; Urquidi C; Rodriguez N; Castillo L; Fernández J; Ramírez E
    J Med Virol; 2021 Jul; 93(7):4334-4341. PubMed ID: 33713457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibodies in Australia After the First Epidemic Wave in 2020: A National Survey.
    Vette KM; Machalek DA; Gidding HF; Nicholson S; O'Sullivan MVN; Carlin JB; Downes M; Armstrong L; Beard FH; Dwyer DE; Gibb R; Gosbell IB; Hendry AJ; Higgins G; Hirani R; Hueston L; Irving DO; Quinn HE; Shilling H; Smith D; Kaldor JM; Macartney K
    Open Forum Infect Dis; 2022 Mar; 9(3):ofac002. PubMed ID: 35169588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study.
    Trieu MC; Bansal A; Madsen A; Zhou F; Sævik M; Vahokoski J; Brokstad KA; Krammer F; Tøndel C; Mohn KGI; Blomberg B; Langeland N; Cox RJ;
    J Infect Dis; 2021 Feb; 223(4):589-599. PubMed ID: 33247924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of virus neutralization activity and results of 10 different anti-SARS-CoV-2 serological tests in COVID-19 recovered plasma donors.
    Szabó Z; Szabó T; Bodó K; Kemenesi G; Földes F; Kristóf K; Barabás E; Vásárhelyi B; Prohászka Z; Fodor E; Jakab F; Berki T; Lacza Z
    Pract Lab Med; 2021 May; 25():e00222. PubMed ID: 33898689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
    Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
    Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Multidimensional Cross-Sectional Analysis of Coronavirus Disease 2019 Seroprevalence Among a Police Officer Cohort: The PoliCOV-19 Study.
    Sendi P; Baldan R; Thierstein M; Widmer N; Gowland P; Gahl B; Büchi AE; Güntensperger D; Wider M; Blum MR; Tinguely C; Maillat C; Theel ES; Berbari E; Dijkman R; Niederhauser C
    Open Forum Infect Dis; 2021 Dec; 8(12):ofab524. PubMed ID: 34888394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility to Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Children and Adults: A Seroprevalence Study of Family Households in the Barcelona Metropolitan Region, Spain.
    Brotons P; Launes C; Buetas E; Fumado V; Henares D; de Sevilla MF; Redin A; Fuente-Soro L; Cuadras D; Mele M; Jou C; Millat P; Jordan I; Garcia-Garcia JJ; Bassat Q; Muñoz-Almagro C;
    Clin Infect Dis; 2021 Jun; 72(12):e970-e977. PubMed ID: 33180914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme-Linked Immunosorbent Assay for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) IgM/IgA and IgG Antibodies Among Healthcare Workers.
    Alharbi SA; Almutairi AZ; Jan AA; Alkhalify AM
    Cureus; 2020 Sep; 12(9):e10285. PubMed ID: 33047077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Cell-Based ELISA to Improve the Serological Analysis of Anti-SARS-CoV-2 IgG.
    Zarletti G; Tiberi M; De Molfetta V; Bossù M; Toppi E; Bossù P; Scapigliati G
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33171590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers.
    Patel EU; Bloch EM; Clarke W; Hsieh YH; Boon D; Eby Y; Fernandez RE; Baker OR; Keruly M; Kirby CS; Klock E; Littlefield K; Miller J; Schmidt HA; Sullivan P; Piwowar-Manning E; Shrestha R; Redd AD; Rothman RE; Sullivan D; Shoham S; Casadevall A; Quinn TC; Pekosz A; Tobian AAR; Laeyendecker O
    J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33139419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers.
    Irsara C; Egger AE; Prokop W; Nairz M; Loacker L; Sahanic S; Pizzini A; Sonnweber T; Holzer B; Mayer W; Schennach H; Loeffler-Ragg J; Bellmann-Weiler R; Hartmann B; Tancevski I; Weiss G; Binder CJ; Anliker M; Griesmacher A; Hoermann G
    Clin Chem Lab Med; 2021 Jul; 59(8):1453-1462. PubMed ID: 33837679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of SARS-CoV-2 antibodies in over 6000 healthcare workers in Spain.
    Varona JF; Madurga R; Peñalver F; Abarca E; Almirall C; Cruz M; Ramos E; Castellano Vázquez JM
    Int J Epidemiol; 2021 May; 50(2):400-409. PubMed ID: 33434269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.